Thus, the conserved impact of white adipocyte cellular metabolism and adipocyte inflammation in both mice and humans invoke the potential relevance of the IFN-I/PKM2 axis in progression of obesity-associated metabolic and nonmetabolic diseases in humans. The gene discussed is PKM; the disease is obesity disorder.